EGFR and non-small cell lung carcinoma: Elevated glycosylated ceramide and sphingomyelin species were detected in lung pleural effusions from NSCLC patients26, but to date, resistance to clinically approved kinase inhibitors of EGFR has never been associated with the aberrant synthesis of simple or complex glycosphingolipids.